Nicholas Company’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,955
Closed -$3.94M 215
2024
Q4
$3.94M Sell
16,955
-5
-0% -$1.15K 0.06% 208
2024
Q3
$3.74M Sell
16,960
-5,970
-26% -$1.24M 0.06% 210
2024
Q2
$4.51M Sell
22,930
-5,575
-20% -$1.15M 0.08% 195
2024
Q1
$6.14M Sell
28,505
-9,115
-24% -$1.91M 0.1% 183
2023
Q4
$7.92M Hold
37,620
0.14% 136
2023
Q3
$7.53M Sell
37,620
-155
-0.4% -$30.8K 0.15% 133
2023
Q2
$7M Hold
37,775
0.13% 157
2023
Q1
$7.23M Buy
+37,775
New +$6.83M 0.15% 153

Other funds holding CME

Nicholas Company's CME Position: Q1 2025 in Review

Nicholas Company sold out of CME Group (CME) in Q1 2025, closing a stake of 16,955 shares — an estimated $3.94M sold.

Nicholas Company first reported a position in CME in Q1 2023 and held it in 8 quarters. The position peaked at $7.92M in Q4 2023. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • Nicholas Company reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
  • Nicholas Company sold 16,955 CME Group shares in Q1 2025, an estimated $3.94M.
  • Nicholas Company first reported a position in CME Group in Q1 2023 and held it in 8 quarters.
  • Nicholas Company's CME Group position peaked at $7.92M in Q4 2023.
  • 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Nicholas Company's 13F filing for Q1 2025, filed 8 May 2025.